Skip to main content
. 2021 Feb 15;2021(2):CD013109. doi: 10.1002/14651858.CD013109.pub2

1.12. Analysis.

1.12

Comparison 1: Aldosterone antagonists (spironolactone or eplerenone) versus control (placebo or usual care), Outcome 12: Residual kidney function [urine volume/day]